About Christoph Schäfer

This author has not yet filled in any details.
So far Christoph Schäfer has created 59 blog entries.

CIS Pharma has reached the first milestone in its SNI funded project

Bubendorf, Switzerland, Thursday, December 21, 2017 - CIS Pharma’s bio-membrane project has reached the first milestone. The polymer chemistry experts developed the a first prototype compatible with the 3D printing [...]

CIS Pharma Christmas event at Palazzo Colombino

Basel, Switzerland, Friday, December 8, 2017 - We spend the night at Palazzo Colombino, a Variété that offers a night with delishes food and spectacular artistic performances. The exquisite dishes [...]

CIS Pharma team attends CPhI Worlwide 2017 in Frankfurt

Frankfurt, Germany, Tuesday to Thursday, October 24 to 26, 2017 – CIS Pharma is attending CPhI Worlwide to meet development partners and licensees during the three-day conference in Frankfurt. The [...]

CIS Pharma verified compatibility of its polymer-drug carriers to be used in antibody-drug conjugates and antibody-radionuclid conjugates

Bubendorf, Switzerland, Monday, October 16, 2017 - The polymer experts from CIS Pharma successfully accomplished a first proof-of-concept study on the compatibility of their polymer-drug carriers with a conjugation technique [...]

Mylotarg, a new antibody-drug conjugate, ADC, approved by the FDA for treatment of acute myeloid leukemia

Maryland, USA, Friday, September 1, 2017 - The U.S. Food and Drug Administration approved the ADC Mylotarg, gemtuzumab ozogamicin, for the treatment of adults with newly diagnosed acute myeloid leukemia, [...]

CIS Pharma summer event in Alsace

Strasbourg, France, Thursday, July 20, 2017 - The CIS Pharma Summer Event takes us to Alsace, France. Our first stop is well known in France and abroad for its foie [...]

Besponsa, a new antibody-drug conjugate, ADC, approved in the EU

London, GB, Thursday, June 29, 2017 - The ADC Besponsa - inotuzumab ozogamicin, Pfizer Inc. - is a cancer medicine used to treat a type of blood cancer which affects [...]

CIS Pharma presenting ADC drug carrier technology at Swiss Biotech Day 2017

Basel, Switzerland, Thursday, May 4, 2017 - CIS Pharma presents its ADC drug carrier technology at Swiss Biotech Day 2017, scheduled for 14:10 during the Emerging Companies Streams. CIS Pharma [...]

CIS Pharma starts R&D project by SNI for 3D printed biocompatible membranes for tissue regeneration

Bubendorf, Switzerland, Wednesday, April 26, 2017 - The Swiss Nanoscience Institute has granted CIS Pharma funding for an innovative project in the field of implantology. The Project is a collaboration [...]

CIS Pharma team attends Pharmapack 2017 in Paris

Paris, France, Wednesday to Thursday, February 1 to 2, 2017 – CIS Pharma is attending CPhI Worlwide to meet development partners and licensees during the two-day conference in Paris. The [...]